INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 10,900
+90 (0.83%)
At close: Feb 20, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 108.83 billion as of February 20, 2026. Its market cap has increased by 70.85% in one year.
Market Cap
108.83B
Enterprise Value
108.55B
Revenue
7.80B
Ranking
n/a
PE Ratio
4.16
Stock Price
10,900.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 108.83B, a decrease of -50.17%. That is a compound annual growth rate of -3.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 108.83B | 3.91% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 413.78B |
| Hwaseung Enterprise | 319.91B |
| Au Brandz Co.,Ltd | 310.81B |
| BAIKSAN Co,. | 286.37B |
| HWASEUNG Industries | 165.80B |
| Samyang Tongsang | 161.30B |
| The Nature Holdings | 113.14B |
| Uni-Chem | 108.79B |